Clinical Trial Update: Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin in Participants With Chronic Hepatitis C Who Failed Prior Direct-Acting Antiviral Therapy (MK-5172-048) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Grazoprevir + Elbasvir + Ribavirin in Chronic Hepatitis C patients who failed prior direct-acting antivirals; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Elbasvir (elbasvir)
• Grazoprevir (grazoprevir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C Virus | Phase 2 | Status: COMPLETED | Results posted: 2016-03-04